Navigation Links
Sunbathers Beware of Skin Cancer, Dermatologists Warn

2002, when deaths were slightly higher at about 9,900, according to the U.S. Centers for Disease Control and Prevention (CDC).

In New Jersey, new melanoma cases rose by about 50 percent from 1999 through 2002, then dipped slightly in 2003, the latest year for which data are available.

Including less dangerous skin cancers such as basal cell and squamous cell carcinoma, there are more than 1 million new U.S. cases a year, almost as many as all other cancers combined, said Alan Conney, director of the Laboratory for Cancer Research at Rutgers University.

Reasons for the increase in cases include the thinning of the ozone layer, use of tanning salons and people going outside more and wearing less clothing compared to decades ago when attire covered more skin, said Conney.

He's been doing tests in mice on two substances that appear to prevent cells whose DNA has been damaged by ultraviolet light from turning cancerous. He's about to start testing them in people to try to develop a protective cream or oral medicine, but that could be years away.

People should check sunscreen labels to see exactly what the product does; the SPF, or sun protection factor, listed on the bottle only refers to protection against ultraviolet B rays, which primarily cause sunburn. UVA rays penetrate the skin more deeply and are the main cause of skin cancer and premature aging, so sunscreens that provide broad UVA and UVB protection are best.

Older sunscreens block UVB rays well, but are less effective against UVA. Newer products do a better job against UVA rays but are much more expensive, Heymann said.

Products with the ingredients Helioplex or Mexoryl are "photo stable," so they aren't broken down quickly by UVA rays and work for a few hours. Chemical-free blockers containing titanium oxide or zinc oxide, which also protect well against both UVA and UVB rays, are a particularly good choice for anyone experiencing r
'"/>




Page: 1 2 3

Related medicine news :

1. Beware of the oral patch! It could be cancer!!!
2. Gardeners, Beware of your back!
3. Beware Smoking During Pregnancy Linked To New Danger
4. Parents Should Beware of Violent Video Games
5. Beware of stroke that trails heart attack
6. Beware Of Bogus Claims by HGH Spray Internet Marketers
7. Beware Of A Silent Killer Called Haemophilia
8. Beware of Cannabis - Not at all a mild drug
9. Beware of Chikungunya !!
10. Hepatitis C : By No Means Lily-livered! Beware
11. Public Alert: Beware of fake glucose test strips!!
Post Your Comments:
(Date:8/29/2008)...l., Aug. 29 /PRNewswire-FirstCall/ -- Landauer, In...irectors declared a regular,quarterly cash dividen...cal,2008. The dividend will be paid on October 3, ...008., About Landauer, Landauer is the leading pr...ional and environmental radiation exposure. For mo...
(Date:8/29/2008)... AMD presents Telemedicine Encounter Mana... State delegations as a possible solution to natio... N.Chelmsford, MA (PRWEB) August 29, 2008 -- If ...by the speakers at the Democratic National Convent...esolve our national health care issues., , ,Our De...
(Date:8/28/2008)...with person with dementia led to daytime tiredness...ug. 28 (HealthDay News) -- Older adults who live w...omeone with dementia have significantly worse slee..., The study compared 31 caregivers and 102 nonc...3 minutes less per night than non-caregivers and t...
(Date:8/28/2008)...f., Aug. 28 /PRNewswire-FirstCall/ -- ISTA Pharmac...t will present at the Thomas Weisel,Partners Healt...rsday,September 4, 2008 at the Four Seasons Hotel...tive Officer, Vicente Anido, Jr.,Ph.D., will prov...ical,progress. To access the live audio broadcast ...
Breaking Medicine News(10 mins):Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
Plump Infants Getting Obese Later In Life In More Cases
...ound that there is no link whatsoever between brea...atins or lipid lowering drugs //to control the sam...October 24 issue of Archives of Internal Medicine,... article says that although some evidence has been...
... likely to invoke the compulsory licensing (CL) pr...tic drug //firms to produce and stockpile Swiss dr...combating the global threat against the most dread...ers the government to issue CL without receipt of ...
...ial lung disease (ILD) comprises a large, heteroge...rized by diffuse infiltrates, restrictive lung dis...mortality and morbidity. ILD presents enormous dia...ial diagnosis includes more than 100 conditions in...
Other Medicine News:Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
(Date:8/28/2008)... to collaborate on studies of immunosuppression ...diated immunity, COLUMBIA, Md., Aug. 28 /PRNewswi...n distributor, Sun Woo Biotech, is delighted to be...enter trial of the ImmuKnow assay,for cell-mediate...tutions,in the Republic of Korea," stated Brad Ste...
(Date:8/28/2008)... /- Intercell AG (VSE: ICLL) today,an...s initiated a Phase II,clinical trial of V710, an ...hylococcus aureus (S. aureus) infections. This ran...s to evaluate the safety and immunogenicity of,the...ey disease on,hemodialysis. This trial start follo...
(Date:8/27/2008)...in Parts of Bucks, Delaware, Montgomery,Philadelp...e-USNewswire/ -- After encouraging,results followi...tment of,Environmental Protection will continue it...st the mosquito-borne West Nile virus., Targeted ....m. and,midnight in portions of Bucks, Delaware, M...
(Date:8/27/2008)..., melphalan and prednisone arm demonstrated a, si... complete response -, CAMBRIDGE, Mass., Aug. 27 /...pany today announced the publication of results fr... trial in this week,s edition of the,New England J...nt survival,benefit and a 30 percent complete remi...
Breaking Medicine Technology:Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 3Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 1State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 2State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 3State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 4CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 1885 1CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 1885 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 1Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 3Penn researchers find monkeys able to fend off AIDS like symptoms with enhanced HIV vaccine 1293 1Penn researchers find monkeys able to fend off AIDS like symptoms with enhanced HIV vaccine 1293 2
...ncer Conference, NORTH HOLLYWOOD, Calif., and CHIC...al Myeloma Foundation (IMF)-supporting research,an...eloma patients,families, researchers and physicia...e 3 multi- national clinical trial shows the,combi...obability of,survival by 41%. The follow-up study ...
...ity Support Development of Panzem(R),NCD as a Comb...ILLE, Md., June 05, 2007 /PRNewswire-FirstCall/ --...company developing,therapeutics for the treatment ... presentation of results of a single-agent Phase 2...lioblastoma,multiforme (GBM). The data were presen...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 3Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 4
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: